Template:Ergotamine: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 42: Line 42:
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Ergotamine|{{fontcolor|#6C7B8B|Ergotamine}}]]'''''
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Ergotamine|{{fontcolor|#6C7B8B|Ergotamine}}]]'''''
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | medihaler ergotamine (ergotamine tartrate)  aerosol, metered  [3M Riker] <sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Medihaler ergotamine (ergotamine tartrate)  aerosol, metered  [3M Riker] <sup>®</sup> FDA Package Insert
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ergotamine indications and usage|Indications and Usage]]

Revision as of 02:24, 11 February 2014